
Inside Aesthetics Ep 246 AnteAGE: Regenerative Skin Care Utilising Exosomes & Growth Factors | Ian Sanderson & Dr Steven Liew
Episode 246 hosts Ian Sanderson (President of AnteAGE®) & Dr Steven Liew (Plastic Surgeon based in Sydney, Australia).
AnteAGE® are regenerative skincare company based in California, USA. Their mission is to provide powerful regenerative anti-aging products through evidence-based technologies. They have pioneered the use of human bone marrow stem cell technology both for aesthetic and dermatological uses, utilising exosomes and growth factors respectively.
In this episode we go on a deep dive to try to understand the proposed mechanisms of these novel products. We differentiate between what exosomes are vs growth factors, how they are used in clinic vs at home and what the likely outcomes might be for our patients.
This episode was supported by AnteAGE
00:00 Introduction 00:37 Regenerative Medicine Returns 01:08 Podcast Competition Update 01:55 Partner Offer Clinical Imaging 03:20 Partner Offer PHILM 04:14 Patreon and Clinic Content 05:16 Meet our Guests: Ian Sanderson & Dr Steven Liew 06:23 Antioch Origin Story 07:56 Steven Li on Regeneration 09:25 Defining Regenerative Medicine 12:54 Stem Cells Ethics and Signals 16:15 Cytokines and Growth Factors 101 18:53 Why Bone Marrow Stem Cells 22:43 What Are Exosomes 27:26 Sourcing and Safety Testing 30:32 Human vs Plant Animal Exosomes 32:40 Clinical Uses and Treatment Menu 38:12 Patient Concerns and Adoption 40:08 Safety and Adoption Proof 41:47 What Exosomes Really Do 45:22 Aesthetic Results and Glow 48:52 Protocols and Product Stack 52:17 Injectables and Regulations 56:55 Stability and Skin Delivery 01:00:11 Clinic Workflow and Mixing 01:03:58 Evidence and White Papers 01:05:21 Pricing Margins and PRP 01:10:20 Hair Loss and Future Tech 01:11:54 Marketing Within Guidelines 01:16:10 Wrap Up and Special Offer
*****APPLY FOR OUR IA COMPETITION*****
Click here to read our Instagram post for details of the prize and how to apply!
ALL IA LINKS & CONTACT INFORMATION
